文献速递皮肤肿瘤

复发性转移性黑色素瘤克隆组成与新抗原景观的动态演化

Dynamic Evolution of Clonal Composition and Neoantigen Landscape in Recurrent Metastatic Melanoma with a Rare Combination of Driver Mutations.
PubMed 文献 · J Invest Dermatol · 2019-02-15

该研究对一例6年内反复出现皮肤病灶但未发生皮肤外转移的非典型黑色素瘤进行全外显子测序,分析4个皮肤病灶的克隆组成和新抗原景观演化。发现晚期肿瘤亚克隆单核苷酸变异较少且新抗原负荷降低,提示新抗原驱动的克隆选择;同时鉴定出MAP2K1(F53Y)错义突变和AKAP9-BRAF融合,两者协同激活MAPK通路,为潜在驱动突变。

要点

  • 黑色素瘤克隆演化部分由高新抗原负荷亚克隆的反向选择驱动
  • MAP2K1 F53Y与AKAP9-BRAF融合协同激活MAPK通路,为潜在驱动突变
  • 同一患者6年皮肤病灶遗传演化伴意外表型稳定

核心结论

  • 该非典型黑色素瘤在6年皮肤病灶反复过程中呈现新抗原驱动的克隆选择,并鉴定出MAP2K1 F53Y与AKAP9-BRAF融合为潜在驱动突变。

研究设计与样本

  • 对一例6年内反复出现皮肤病灶但无皮肤外转移的非典型黑色素瘤患者的4个皮肤病灶进行全外显子测序。

主要发现

  • 所有肿瘤共享一组单核苷酸变异和小插入缺失,晚期肿瘤 Progressive 选择出单核苷酸变异较少的亚克隆。
  • 晚期肿瘤新抗原负荷低于早期肿瘤,提示克隆演化部分由高新抗原负荷亚克隆的反向选择驱动。
  • 选择的突变包括MAP2K1(F53Y)错义突变和7号染色体倒位产生的AKAP9-BRAF融合。
  • 突变蛋白协同激活MAPK信号通路,证实其为该肿瘤的潜在驱动突变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In melanoma, initiating oncogenic mutations in BRAF or NRAS are detected in premalignant lesions that accumulate additional mutations and genomic instability as the tumor evolves to the metastatic state. Here we investigate evolution of clonal composition and neoantigen landscape in an atypical melanoma displaying recurrent cutaneous lesions over a 6-year period without development of extracutaneous metastases. Whole exome sequencing of four cutaneous lesions taken during the 6-year period identified a collection of single nucleotide variants and small insertions and deletions shared among all tumors, along with progressive selection of subclones displaying fewer single nucleotide variants. Later tumors also displayed lower neoantigen burden compared to early tumors, suggesting that clonal evolution was driven, at least in part, by counter selection of subclones with high neoantigen burdens. Among the selected mutations are a missense mutation in MAP2K1 (F53Y) and an inversion on chromosome 7 generating a AKAP9-BRAF fusion. The mutant proteins cooperatively activate the MAPK signaling pathway confirming they are potential driver mutations of this tumor. We therefore describe the long-term genetic evolution of cutaneous metastatic melanoma characterized by an unexpected phenotypic stability and neoantigen-driven clonal selection.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Davidson G, Coassolo S, Kieny A, et al. Dynamic Evolution of Clonal Composition and Neoantigen Landscape in Recurrent Metastatic Melanoma with a Rare Combination of Driver Mutations. J Invest Dermatol. 2019. PMID: 30776432. doi:10.1016/j.jid.2019.01.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。